Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Allaway

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nanotoxicology|November 25, 2010
Gold nanoparticle trafficking of typically excluded compounds across the cell membrane in JB6 Cl 41-5a cells causes assay interferenceAthena M Keene, Robert J Allaway, Nakissa Sadrieh, et al.
Journal of Cheminformatics|August 22, 2018
Probing the chemical-biological relationship space with the Drug Target ExplorerRobert J Allaway, Salvatore La Rosa, Justin Guinney, et al.
Nature Methods|May 29, 2023
Machine learning in rare diseaseJineta Banerjee, Jaclyn N Taroni, Robert J Allaway, et al.
BMC Genomics|February 8, 2017
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastomaGregory P Way, Robert J Allaway, Stephanie J Bouley, et al.
British Journal of Cancer|April 27, 2018
Cutaneous neurofibromas in the genomics era: current understanding and open questionsRobert J Allaway, Sara J C Gosline, Salvatore La Rosa, et al.
Scientific Data|December 15, 2019
Engaging a community to enable disease-centric data sharing with the NF Data PortalRobert J Allaway, Salvatore La Rosa, Sharad Verma, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 24, 2022
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosisJineta Banerjee, Jan M Friedman, Laura J Klesse, et al.
Genes|February 27, 2020
Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1Jineta Banerjee, Robert J Allaway, Jaclyn N Taroni, et al.
Oncotarget|April 18, 2018
Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cellsRobert J Allaway, Matthew D Wood, Sondra L Downey, et al.
Cancer Discovery|October 24, 2018
Spatiotemporal Loss of <i>NF1</i> in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo PathwayZhiguo Chen, Juan Mo, Jean-Philippe Brosseau, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nanotoxicology|November 25, 2010
Gold nanoparticle trafficking of typically excluded compounds across the cell membrane in JB6 Cl 41-5a cells causes assay interferenceAthena M Keene, Robert J Allaway, Nakissa Sadrieh, et al.
Journal of Cheminformatics|August 22, 2018
Probing the chemical-biological relationship space with the Drug Target ExplorerRobert J Allaway, Salvatore La Rosa, Justin Guinney, et al.
Nature Methods|May 29, 2023
Machine learning in rare diseaseJineta Banerjee, Jaclyn N Taroni, Robert J Allaway, et al.
BMC Genomics|February 8, 2017
A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastomaGregory P Way, Robert J Allaway, Stephanie J Bouley, et al.
British Journal of Cancer|April 27, 2018
Cutaneous neurofibromas in the genomics era: current understanding and open questionsRobert J Allaway, Sara J C Gosline, Salvatore La Rosa, et al.
Scientific Data|December 15, 2019
Engaging a community to enable disease-centric data sharing with the NF Data PortalRobert J Allaway, Salvatore La Rosa, Sharad Verma, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 24, 2022
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosisJineta Banerjee, Jan M Friedman, Laura J Klesse, et al.
Genes|February 27, 2020
Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1Jineta Banerjee, Robert J Allaway, Jaclyn N Taroni, et al.
Oncotarget|April 18, 2018
Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cellsRobert J Allaway, Matthew D Wood, Sondra L Downey, et al.
Cancer Discovery|October 24, 2018
Spatiotemporal Loss of <i>NF1</i> in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo PathwayZhiguo Chen, Juan Mo, Jean-Philippe Brosseau, et al.
Pageof 2